Deciphera Pharmaceuticals
Stock Forecast, Prediction & Price Target
Deciphera Pharmaceuticals Financial Estimates
Deciphera Pharmaceuticals Revenue Estimates
Deciphera Pharmaceuticals EBITDA Estimates
Deciphera Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $96.14M N/A | $134.03M 39.40% | $163.35M 21.87% | Avg: $265.11M Low: $219.22M High: $403.10M avg. 62.29% | Avg: $376.56M Low: $345.40M High: $443.78M avg. 42.03% | Avg: $531.41M Low: $487.44M High: $626.27M avg. 41.12% | Avg: $381.36M Low: $349.80M High: $449.43M avg. -28.23% |
Net Income
% change YoY
| $-296.83M N/A | $-178.93M 39.72% | $-194.94M -8.94% | Avg: $-157.01M Low: $-215.20M High: $-46.78M avg. 19.45% | Avg: $-71.75M Low: $-166.71M High: $133.54M avg. 54.30% | Avg: $49.67M Low: $44.33M High: $61.20M avg. 169.23% | Avg: $-5.95M Low: $-7.33M High: $-5.31M avg. -111.98% |
EBITDA
% change YoY
| $-300.07M N/A | $-182.72M 39.10% | $-208.85M -14.30% | Avg: $-265.11M Low: $-403.10M High: $-219.22M avg. -26.93% | Avg: $-376.56M Low: $-443.78M High: $-345.40M avg. -42.03% | Avg: $-531.41M Low: $-626.27M High: $-487.44M avg. -41.12% | Avg: $-381.36M Low: $-449.43M High: $-349.80M avg. 28.23% |
EPS
% change YoY
| -$5.11 N/A | -$2.37 53.62% | -$2.29 3.37% | Avg: -$1.65 Low: -$2.53 High: -$0.55 avg. 28.00% | Avg: -$0.72 Low: -$1.96 High: $1.57 avg. 56.50% | Avg: $0.58 Low: $0.52 High: $0.72 avg. 181.43% | Avg: -$0.07 Low: -$0.09 High: -$0.06 avg. -111.98% |
Operating Expenses
% change YoY
| $393.29M N/A | $307.98M -21.68% | $370.58M 20.32% | Avg: $455.16M Low: $376.37M High: $692.07M avg. 22.82% | Avg: $646.49M Low: $593.00M High: $761.90M avg. 42.03% | Avg: $912.36M Low: $836.86M High: $1.07B avg. 41.12% | Avg: $654.74M Low: $600.56M High: $771.62M avg. -28.23% |
FAQ
What is Deciphera Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 32.75% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -215.20M, average is -157.01M and high is -46.78M.
What is Deciphera Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 29.30% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $219.22M, average is $265.11M and high is $403.10M.
What is Deciphera Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 38.48% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$2.53, average is -$1.65 and high is $-0.55.
What is the best performing analyst?
In the last twelve months analysts have been covering Deciphera Pharmaceuticals stock. The most successful analyst is Peter Lawson.